APA (7th ed.) Citation

Böhm, M., Butler, J., Coats, A., Lauder, L., Mahfoud, F., Filippatos, G., . . . Anker, S. D. (2025). Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: The EMPEROR-Preserved trial : clinical research : hypertension. European heart journal, 46(14), . https://doi.org/10.1093/eurheartj/ehae938

Chicago Style (17th ed.) Citation

Böhm, Michael, et al. "Empagliflozin in Resistant Hypertension and Heart Failure with Preserved Ejection Fraction: The EMPEROR-Preserved Trial : Clinical Research : Hypertension." European Heart Journal 46, no. 14 (2025). https://doi.org/10.1093/eurheartj/ehae938.

MLA (9th ed.) Citation

Böhm, Michael, et al. "Empagliflozin in Resistant Hypertension and Heart Failure with Preserved Ejection Fraction: The EMPEROR-Preserved Trial : Clinical Research : Hypertension." European Heart Journal, vol. 46, no. 14, 2025, https://doi.org/10.1093/eurheartj/ehae938.